Thomas A. Furman v. Daniel Cherry

Court of Appeals for the Eleventh Circuit·Decided September 11, 2020·No. 19-14134·Unpublished

Opinion

[DO NOT PUBLISH]

IN THE UNITED STATES COURT OF APPEALS

FOR THE ELEVENTH CIRCUIT

No. 19-14134

Non-Argument Calendar

D.C. Docket No. 4:16-cv-00214-MW-CAS

THOMAS A. FURMAN,

Plaintiff-Appellant,

Cross Appellee,

versus

WARDEN, et al., Defendants,

DANIEL CHERRY, Dr. Regional Medical Director,

Defendant-Appellee,

Cross Appellant,

THOMAS REIMERS, Dr. Assistant Secretary of Health Services,

Defendant-Appellee.

Appeal from the United States District Court for the Northern District of Florida

(September 11, 2020)

Before MARTIN, ROSENBAUM, and EDMONDSON, Circuit Judges.

PER CURIAM:

In this civil action under 42 U.S.C. § 1983, the district court concluded that defendant prison officials 1 violated the Eighth Amendment by delaying medical treatment for Thomas Furman’s hepatitis C viral infection (“HCV”). Furman, a state prisoner proceeding pro se, 2 appeals the district court’s denial of Furman’s

1 In the operative complaint, Furman named as Defendants (1) Dr. Daniel Cherry, the Regional Medical Director for the Florida Department of Corrections (“FDOC”), in his official and individual capacities; (2) the Assistant Secretary for FDOC’s Department of Health Services (Dr. Ogunsanwo), in his official capacity; (3) the prison’s Medical Director (Dr. Matos); and (4) an employee in the FDOC’s Central Office (Ebony Harvey). Dr. Ogunsanwo was later substituted as a defendant by the FDOC’s current Director of Health Services (Thomas Reimers), in his official capacity.

On appeal, Furman raises no challenge to the district court’s dismissal of Dr. Matos for insufficient service of process or to the district court’s grant of Defendant Harvey’s motion to dismiss. Only Defendants Dr. Cherry and Mr. Reimers are parties to this appeal.

2 We construe liberally pro se pleadings. Tannenbaum v. United States, 148 F.3d 1262, 1263 (11th Cir. 1998).

claims for compensatory and for punitive damages. Defendant Dr. Cherry cross- appeals the district court’s award of nominal damages in favor of Furman. Reversible error has been shown; we affirm in part and vacate in part the final judgment, and remand for further proceedings.

Furman filed his initial pro se complaint in 2016, while Furman was in the custody of the Florida Department of Corrections (“FDOC”). 3 Furman alleged that defendants’ refusal to provide a liver biopsy and needed medical treatment for his HCV -- as recommended by prison doctors -- constituted deliberate indifference to Furman’s serious medical needs.

The district court ordered Furman to file an amended complaint on a court-

approved form. In his second amended pro se complaint, Furman reasserted his claim for deliberate indifference in violation of the Eighth Amendment. Furman alleged he was diagnosed with HCV upon his incarceration in 2004. Over the years, Furman got some medical attention. Furman’s HCV remained untreated, however, despite the medical recommendations of seven FDOC doctors and Furman’s formal grievances. Because treatment is expensive, Furman said the FDOC had a policy of providing HCV treatment only after a prisoner’s liver began showing “signs of deterioration due to the virus.” Furman alleged that Dr. Cherry

3 In May 2019, Furman was released from the FDOC’s custody and was transferred by extradition to Illinois.

was responsible for making final decisions on treatment recommendations and that Dr. Cherry had denied Furman’s formal grievances that requested needed medical treatment for his HCV. As relief, Furman sought injunctive relief and compensatory and punitive damages.

The district court later stayed the proceedings in Furman’s suit pending the resolution of a related, class-action lawsuit in Hoffer, et al. v. Jones, N.D. Fla. Case No. 4:17-cv-00214-MW-CAS, in which Furman was a named class member. The district court ordered Defendants in this civil action to provide regular status reports updating the court on the proceedings in Hoffer.

In an April 2018 status report, Defendants reported that -- pursuant to the district court’s mandates in Hoffer -- over 21,000 Florida inmates had been screened for HCV. Through this process, Furman was identified as having chronic HCV. The status report provided, however, that Furman’s January 2018 lab results were “normal.”

Furman objected to the April 2018 status report as presenting false information about his lab results. Furman attached a copy of his January 2018 lab results, which showed that Furman’s “fibrosis score” was 0.67: a score that

indicated “advanced fibrosis” and put Furman in the F3 category on the METAVIR scale.4 Defendants’ July 2018 status report indicated that Furman was only at the F2 stage. Furman again objected that his test results showed he was “at the Fibrosis- F3 advanced stage” and remained untreated.

Defendants’ September 2018 status report provided that the district court in Hoffer had entered a preliminary injunction requiring that inmates at the F3 stage receive HCV treatment before December 2018.5 Defendants reported that Furman had “progressed from the F2 stage to the F3 stage” and, thus, began HCV treatment in August 2018.

In October 2018, the district court lifted the stay in this case. The district court explained that -- although Hoffer rendered moot Furman’s request for injunctive relief -- Furman’s request for damages remained unresolved.

The parties filed cross-motions for summary judgment. In support of their motions for summary judgment, Defendants attached declarations from two

4 Under the METAVIR scale -- which is used to measure the severity of liver scarring in patients with HCV -- a person can be classified as F0 (no fibrosis), F1 (mild fibrosis), F2 (moderate fibrosis), F3 (severe fibrosis), or F4 (cirrhosis). 5 See Hoffer v. Jones, 290 F. Supp. 3d 1292 (N.D. Fla. 2017) (concluding that the FDOC had “not treated HCV-infected inmates as required by the Constitution” and entering a preliminary injunction to “ensure that inmates with HCV receive[d] medical care in a timely manner.”). The district court in Hoffer later entered a permanent injunction against the FDOC. See Hoffer v. Inch, 382 F. Supp. 3d 1288 (N.D. Fla. 2019), rev’d in part, vacated in part sub nom. Hoffer v. Fla. Dep’t of Corr., No. 19-11921, 2020 U.S. App. LEXIS 27654 (11th Cir. Aug. 31, 2020).

medical doctors: an FDOC doctor (Dr. W) and a third-party contractor who worked as the Statewide Medical Director for the FDOC (Dr. L).

According to Dr. W, Furman’s medical records showed that Furman completed his 12-week HCV treatment regimen in November 2018. Furman was scheduled for a six-month follow-up in May 2019 “to confirm that his viral load was undetectable.” Dr. W opined that “[s]o long as [Furman] does not consume drugs or alcohol and takes proper care of himself going forward, his long-term prognosis is very good.” In addition, Dr. W said that Furman “should not experience any future liver problems or any ill effects related to Hep-C following the completion of successful treatment with Zepatier.”

Dr. L reported that Furman’s February 2019 lab results indicated that Furman’s HCV viral load was “not detected.” Furman was thus deemed “cured” of HCV. Dr. L opined that -- based on Furman’s lab results and imaging studies -- Furman suffered no physical injuries resulting from his HCV infection. Dr. L said that Furman’s “long-term prognosis is very good and he should not experience any liver damage related to Hepatitis-C” as long as Furman avoids drugs and alcohol and “otherwise maintains a healthy lifestyle.”

Free access — add to your briefcase to read the full text and ask questions with AI

Thomas A. Furman v. Daniel Cherry, (11th Cir. 2020).

Thomas A. Furman v. Daniel Cherry (Thomas A. Furman v. Daniel Cherry) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Alexander v. Tippah County MS
351 F.3d 626 (Fifth Circuit, 2003)
Tannenbaum v. United States
148 F.3d 1262 (Eleventh Circuit, 1998)
Harris v. Garner
190 F.3d 1279 (Eleventh Circuit, 1999)
Ned Hughes v. Charles Lott
350 F.3d 1157 (Eleventh Circuit, 2003)
John Ruddin Brown v. Lisa Johnson
387 F.3d 1344 (Eleventh Circuit, 2004)
Smith v. Allen
502 F.3d 1255 (Eleventh Circuit, 2007)
Mann v. Taser International, Inc.
588 F.3d 1291 (Eleventh Circuit, 2009)
Carey v. Piphus
435 U.S. 247 (Supreme Court, 1978)
Hudson v. McMillian
503 U.S. 1 (Supreme Court, 1992)
Farrar v. Hobby
506 U.S. 103 (Supreme Court, 1992)
Flanory v. Bonn
604 F.3d 249 (Sixth Circuit, 2010)
Al-Amin v. Warden Hugh Smith
637 F.3d 1192 (Eleventh Circuit, 2011)
Fred Dalton Brooks v. Warden
800 F.3d 1295 (Eleventh Circuit, 2015)
Pierce v. County of Orange
526 F.3d 1190 (Ninth Circuit, 2008)
William Mitchell v. Warden
873 F.3d 869 (Eleventh Circuit, 2017)
Daaron McAdoo v. Amy Martin
899 F.3d 521 (Eighth Circuit, 2018)
Trent Taylor v. Marion Williams
946 F.3d 211 (Fifth Circuit, 2019)
Hoffer v. Jones
290 F. Supp. 3d 1292 (N.D. Florida, 2017)
Hoffer v. Inch
382 F. Supp. 3d 1288 (N.D. Florida, 2019)